Clinical outcomes of pediatric patients with severe acquired aplastic anemia treated at Siriraj Hospital
Journal of Hematology and Transfusion Medicine · 11.06.2026 · 36 (99)
DOI: 10.69898/jhtm.36.2026.285795 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hematology and Transfusion Medicine, online erschienen am 11.06.2026. Verfasst von Nachapol Jatuten und 1 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Severe acquired aplastic anemia (SAA) is a life-threatening condition. Thai treatment guidelines recommend matched sibling donor hematopoietic stem cell transplantation (MSD-HSCT) and immunosuppressive therapy (IST) combined with eltrombopag (EPAG).
Objective
This study aimed to investigate the clinical outcomes of pediatric patients with SAA treated at Siriraj Hospital.
Method
This retrospective study included pediatric patients with SAA treated at Siriraj Hospital from 1 January 2013 to 31 December 2023.
Result
Twenty-seven patients were enrolled. Treatment modalities included IST in 13 patients (48.2%), IST+EPAG in 7 patients (25.9%) and MSD-HSCT in 7 patients (25.9%). At 3 and 6 months, overall response (OR) rates were 28.6% and 42.9% in the IST+EPAG group and 0% and 7.7% in the IST-only group, respectively. However, these differences were not statistically significant (p = 0.111 and 0.197, respectively). Overall survival (OS) was similar between the IST+EPAG (62.5%, 95%CI: 0.14-0.89) and the IST group (63.3%, 95%CI: 0.29–0.84). The mean time to response and mean time to transfusion independence were shorter in the IST+EPAG group compared with the IST group, but the differences were not statically significance (p = 0.085 and 0.162, respectively). The OS for the MSD-HSCT group was 42.9%.
Conclusion
The combination of EPAG with IST was associated with a trend toward higher OR rates at 3 and 6 months. The IST+EPAG group also demonstrated shorter mean times to hematologic response and transfusion independence. OS was comparable between groups.
Zitieren
APA
Jatuten, N., & Pongtanakul, B. (2026). Clinical outcomes of pediatric patients with severe acquired aplastic anemia treated at Siriraj Hospital. Journal of Hematology and Transfusion Medicine, 36(99). https://doi.org/10.69898/jhtm.36.2026.285795
Vancouver
Jatuten N, Pongtanakul B. Clinical outcomes of pediatric patients with severe acquired aplastic anemia treated at Siriraj Hospital. Journal of Hematology and Transfusion Medicine. 2026;36(99). doi:10.69898/jhtm.36.2026.285795
BibTeX
@article{Jatuten2026,
author = {Jatuten, Nachapol and Pongtanakul, Bunchoo},
title = {Clinical outcomes of pediatric patients with severe acquired aplastic anemia treated at Siriraj Hospital},
journal = {Journal of Hematology and Transfusion Medicine},
year = {2026},
volume = {36},
number = {99},
doi = {10.69898/jhtm.36.2026.285795}
}
EUVIMED